Drug Type Small molecule drug |
Synonyms Drotaverin, Drotaverine, Deolin + [1] |
Target |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC24H32ClNO4 |
InChIKeyJBFLYOLJRKJYNV-UHFFFAOYSA-N |
CAS Registry985-12-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Drotaverine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Muscle Spasticity | CN | - |
Phase 3 | 650 | (Experimental) | otfkaeimgz(bpufncwpva) = tiqopvrfbr xrktkolush (ohjdekhgsv, vsptbdxirr - qfmzvwgbkz) View more | - | 23 Dec 2009 | ||
Hyoscine-N-butylbromide (Active Comparator) | otfkaeimgz(bpufncwpva) = kwsctdepth xrktkolush (ohjdekhgsv, jgstcaruec - yghgbzfqmn) View more |